We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Bionovo Launches Pharmacokinetics Trial of its Lead Menopause Drug Candidate, MF101

News   Jan 22, 2007

 
Bionovo Launches Pharmacokinetics Trial of its Lead Menopause Drug Candidate, MF101
 
 
 

RELATED ARTICLES

Drug Prevents Liver Scarring in People With HIV

News

A new study reports that the injectable hormone tesamorelin reduces liver fat and prevents liver fibrosis (scarring) in people living with HIV.

READ MORE

A Way To Extend Survival Rates for Heart Failure?

News

For the first time in preclinical studies, researchers have shown that Aliskiren, a drug that inhibits the enzyme that regulates blood pressure, can delay progression of congestive heart failure and extend survival rates.

READ MORE

Novel Treatment Strategies Could Help Combat the Opioid Crisis

News

Scientists working in the areas of health behavior, neuroscience, pain management and addiction are proposing novel treatment strategies that could help prevent abuse of opioids and other substances.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE